Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2)

Clinical trial NCT03393884 · ACTIVE_NOT_RECRUITING

Trial details

NCT number

NCT03393884

Sponsor

Imunon

Status

ACTIVE_NOT_RECRUITING

Phase

Phase 1, Phase 2

Study type

INTERVENTIONAL

Start date

2018-09-05

Primary completion

2024-07-25

Enrollment

130

View on ClinicalTrials.gov